ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.

In News

Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting - BioSpace

BioSpace - Jan 14, 2026

The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant

BioInformant - Jan 05, 2026

Hatch-Waxman Safe Harbor: Lessons from Recent Court Precedent - IPWatchdog.com

IPWatchdog.com - Jun 10, 2025

Pfizer, biotech firm end patent fight over COVID-19 vaccine - Reuters

Reuters - Jan 05, 2022

Allele, Regeneron Settle COVID Treatment Patent Suit - Law360

Law360 - Dec 16, 2024

Regeneron Antibody Cocktail Used by Trump Faces Patent Suit - Bloomberg.com

Bloomberg.com - Oct 05, 2020

Regeneron loses key defense in COVID-19 treatment patent lawsuit - Reuters

Reuters - Oct 04, 2024

A Guiding Light for the Research Safe Harbor and “Research Tools”? | Proskauer - The Patent Playbook - JD Supra

JD Supra - Jul 21, 2021

Updated Results of Phase 3 ALLELE Study Presented at 66th American Society of Hematology Annual Meeting Confirm Efficacy, Safety and Durability of Novel Allogeneic Cell Therapy Tabelecleucel in Relapsed or Refractory Epstein-Barr Virus Positive Post- - PR Newswire

PR Newswire - Dec 07, 2024

Regeneron, Pfizer and BioNTech Accused of Infringing Allele Patent in Connection with COVID-19 Technologies - IPWatchdog.com

IPWatchdog.com - Oct 07, 2020

Induced Pluripotent Stem Cells Market Size to Hit USD 5.12 Billion by 2034 - Precedence Research

Precedence Research - Aug 01, 2025

Regeneron settles patent lawsuit over protein for testing COVID-19 treatments - Reuters

Reuters - Dec 16, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment